A
Armata Pharmaceuticals, Inc. (ARMP)
ASE – Real vaqt narxi. Valyuta: USD
9.00
+0.18 (2.04%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
ASE – Real vaqt narxi. Valyuta: USD
9.00
+0.18 (2.04%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Armata Pharmaceuticals, Inc. jahon miqyosida antibiotiklarga chidamli infeksiyalar uchun maqsadli bakteriofag terapiyasini ishlab chiqishga qaratilgan klinik bosqichdagi biotexnologiya kompaniyasi sifatida faoliyat yuritadi. Kompaniya o'z mahsulotlarini o'ziga xos bakteriofag asosidagi texnologiyasidan foydalangan holda ishlab chiqadi. Kompaniyaning mahsulot nomzodlari orasida Staphylococcus aureus bakteriyemiyasini davolash uchun AP-SA02; Pseudomonas aeruginosa uchun AP-PA03 mavjud. Kompaniya Los-Anjeles, Kaliforniyada joylashgan. Armata Pharmaceuticals, Inc. Innoviva, Inc. kompaniyasining sho'ba korxonasidir.
| Ism | Lavozim |
|---|---|
| Dr. Deborah L. Birx M.D. | CEO & Director |
| Dr. Pierre Kyme Ph.D. | Chief Business Officer |
| Mr. David D. House | Senior VP of Finance & Principal Financial Officer |
| Mr. Peter Hubbard | Vice President of Operations |
| Ms. Bani Tchekanova Ph.D. | Head of Regulatory Strategy & Operations |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-07 | 8-K | tm2613773d1_8k.htm |
| 2026-04-27 | DEF 14A | armp-20260611xdef14a.htm |
| 2026-04-27 | 8-K | tm2610924d1_8k.htm |
| 2026-04-02 | 8-K | tm2610924d1_8k.htm |
| 2026-03-25 | 8-K | armp-20260325x8k.htm |
| 2026-03-25 | 10-K | armp-20251231x10k.htm |
| 2026-03-19 | 8-K | tm269341d1_8k.htm |
| 2026-02-23 | 8-K | tm267017d1_8k.htm |
| 2026-01-26 | 8-K | tm263967d1_8k.htm |
| 2026-01-13 | 8-K | tm262898d1_8k.htm |